1 |
Kishimoto3333 Kishimoto Y, Yamamoto Y, Ito T, Matsumoto N, Ichiyoshi H, Katsurada T, et al. Transfer of autoimmune thyroiditis and resolution of palmoplantar pustular psoriasis following allogeneic bone marrow transplantation. Bone Marrow Transplant. 1997;19:1041–3.
|
Acute myeloid leukemia |
Allogeneic |
Two years of follow-up |
2 |
Kaffenberger et al.3232 Kaffenberger BH, Wong HK, Jarjour W, Andritsos LA. Remission of psoriasis after allogeneic, but not autologous, hematopoietic stem-cell transplantation. J Am Acad Dermatol. 2013;68:489–92.
|
Chronic myeloid leukemia |
Allogeneic NST |
Two years of follow-up |
3 |
Kanamori et al.3434 Kanamori H, Tanaka M, Kawaguchi H, Yamaji S, Fujimaki S, Tomita N, et al. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature. Am J Hematol. 2002;71:41–4.
|
Chronic myeloid leukemia |
Allogeneic BMT |
2.5-years of follow-up |
4 |
Mohren et al.3535 Mohren M, Daikeler T, Benz D, Gunaydin I, Kanz L, Kotter I. Myeloablative immunosuppressive treatment with autologous haematopoietic stem cell transplantation in a patient with psoriatic arthropathy and monoclonal gammopathy of undetermined significance. Ann Rheum Dis. 2004;63:466–7.
|
Psoriatic arthritis |
PBSCT |
16-months |
5 |
Woods and Mant2929 Woods AC, Mant MJ. Amelioration of severe psoriasis with psoriatic arthritis for 20 years after allogeneic haematopoietic stem cell transplantation. Ann Rheum Dis. 2006;65:697.
|
Aplastic anemia |
Allogeneic HSCT |
12-months |
6 |
Rossi et al.3636 Rossi HA, Becker PS, Emmons RVB, Westervelt P, Levy W, Liu Q, et al. High-dose cyclophosphamide, BCNU, and VP-16 (CBV) conditioning before allogeneic stem cell transplantation for patients with non-’Hodgkin’s lymphoma. Bone Marrow Transplant. 2003;31:441–6.
|
Acute aplastic anemia |
Allogeneic BMT |
Ten years of follow-up |
7 |
Braiteh et al.3737 Braiteh F, Hymes SR, Giralt SA, Jones R. Complete Remission of Psoriasis After Autologous Hematopoietic Stem-Cell Transplantation for Multiple Myeloma. J Clin Oncol. 2008;26:4511–3.
|
Multiple myeloma |
Autologous HSCT |
> years of follow-up |
8 |
Held et al.3838 Held K, Rahmetulla R, Loew TW, Radhi MA. Complete resolution of guttate psoriasis following autologous SCT for’ Ewing’s sarcoma in a pediatric patient. Bone Marrow Transplant. 2012;47:1585–6.
|
’Ewing’s sarcoma |
Autologous stem cell transplantation |
15-months of follow-up |
9 |
Mori et al.3939 Mori J, Kakihana K, Ohashi K. Sustained remission of psoriasis vulgaris after allogeneic bone marrow transplantation. Br J Haematol. 2012;159:121.
|
Myelodysplastic syndrome |
Allogeneic BMT |
Eight months of follow-up |
10 |
Chen et al.4040 Chen W, Ren G, Zuo K, Huang X. Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation. Medicine (Baltimore). 2018;97:e13589.
|
Immunoglobulin light chain amyloidosis and psoriasis |
Autologous HSCT |
Follow-up for more than 7-years |
11 |
Ugur and Gediz4141 Ugur MC, Gediz F. Evaluation of patients diagnosed with psoriasis and multiple myeloma after autologous stem cell transplantation. Transfus Apher Sci. 2021;60:103137.
|
Psoriasis and multiple myeloma |
Autologous stem cell transplantation |
18-months of follow-up |